Drug · DIN 00513962
TOBREX
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 10, 2018; first marketed December 31, 1981.
- Drug Identification Number (DIN)
- 00513962
- Company (DIN owner)
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Tobramycin S01AA12
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TOBRAMYCIN | 0.3 % | W/V |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 24, 2017: NOC 19564New Drug Submission (NDS) · Transfer of drug identification number
Other DINs named TOBREX
- DIN 00614254 · Marketed